HBC starts its accelerated COVID-19 Phase 2 clinical trial of OmeGo® salmon oil to decrease Acute Respiratory Distress Syndrome and the need for assisted respiration

Completed Annual General Meeting

First Quarter 2020 Financial Report

Preclinical research with OmeGo® demonstrates potential to treat eosinophilic asthma

Two-year research collaboration contract signed with Stanford on the use of Salmon Protein Hydrolysate peptides for the treatment of GI tract diseases in children and adults

Notice of Annual General Meeting 2020

SHARE CAPITAL INCREASE REGISTERED

PRIVATE PLACEMENT TOWARDS BOMI FRAMROZE – PRIMARY INSIDER DISCLOSURE

EU DISTRIBUTION AGREEMENT SIGNED WITH PRINOVA EUROPE FOR MARINE BRANDED PRODUCTS RANGE

MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER IN HOFSETH BIOCARE ASA